These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11231598)

  • 1. Countering the 'counterattack' hypothesis.
    Restifo NP
    Nat Med; 2001 Mar; 7(3):259. PubMed ID: 11231598
    [No Abstract]   [Full Text] [Related]  

  • 2. The Fas signalling pathway and its role in the pathogenesis of cancer.
    Houston A; O'Connell J
    Curr Opin Pharmacol; 2004 Aug; 4(4):321-6. PubMed ID: 15251123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of counterattack of colorectal cancer cell by Fas/Fas ligand system.
    Zhu Q; Liu JY; Xu HW; Yang CM; Zhang AZ; Cui Y; Wang HB
    World J Gastroenterol; 2005 Oct; 11(39):6125-9. PubMed ID: 16273638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance to Fas (APO-1/CD95)-mediated apoptosis and expression of Fas ligand in esophageal cancer: the Fas counterattack.
    O'Connell J; Bennett MW; O'Sullivan GC; Collins JK; Shanahan F
    Dis Esophagus; 1999; 12(2):83-9. PubMed ID: 10466039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand.
    O'Connell J; O'Sullivan GC; Collins JK; Shanahan F
    J Exp Med; 1996 Sep; 184(3):1075-82. PubMed ID: 9064324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specificity questions concerning the clone 33 anti-fas ligand antibody.
    Baker JR; Bretz JD
    Cell Death Differ; 2000 Jan; 7(1):8-9. PubMed ID: 10713715
    [No Abstract]   [Full Text] [Related]  

  • 7. Fas and Fas ligand expressed on cells of the immune system, not on the target tissue, control induction of experimental autoimmune uveitis.
    Wahlsten JL; Gitchell HL; Chan CC; Wiggert B; Caspi RR
    J Immunol; 2000 Nov; 165(10):5480-6. PubMed ID: 11067900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation-induced cell death in T cells and autoimmunity.
    Zhang J; Xu X; Liu Y
    Cell Mol Immunol; 2004 Jun; 1(3):186-92. PubMed ID: 16219166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutting edge: the tumor counterattack hypothesis revisited: colon cancer cells do not induce T cell apoptosis via the Fas (CD95, APO-1) pathway.
    Favre-Felix N; Fromentin A; Hammann A; Solary E; Martin F; Bonnotte B
    J Immunol; 2000 May; 164(10):5023-7. PubMed ID: 10799856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mAb33 from transduction laboratories specifically binds human CD95-L.
    Herr I; Posovsky C; Böhler T; Debatin KM
    Cell Death Differ; 2000 Jan; 7(1):129-30. PubMed ID: 10858072
    [No Abstract]   [Full Text] [Related]  

  • 11. Epithelial ovarian cancer cells secrete functional Fas ligand.
    Abrahams VM; Straszewski SL; Kamsteeg M; Hanczaruk B; Schwartz PE; Rutherford TJ; Mor G
    Cancer Res; 2003 Sep; 63(17):5573-81. PubMed ID: 14500397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profiling tumor counterattack: do Fas ligand-containing microvesicles reduce anticancer immunity?
    Bohana-Kashtan O; Civin CI
    Clin Cancer Res; 2005 Feb; 11(3):968-70. PubMed ID: 15709161
    [No Abstract]   [Full Text] [Related]  

  • 13. Fas (Apo-1/CD95) and Fas ligand interaction between gastric cancer cells and immune cells.
    Lee TB; Min YD; Lim SC; Kim KJ; Jeon HJ; Choi SM; Choi CH
    J Gastroenterol Hepatol; 2002 Jan; 17(1):32-8. PubMed ID: 11895550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in sensitivity of peripheral lymphocytes of autoimmune gld mice to FasL-mediated apoptosis reveal a mechanism for the preferential deletion of CD4-CD8-B220+ T cells.
    Xiao S; Zhang X; Mann KK; Jodo S; Li L; Jarjour WN; Marshak-Rothstein A; Sherr DH; Ju ST
    Int Immunol; 2004 May; 16(5):759-66. PubMed ID: 15096479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The "Fas counterattack": a mechanism for immune evasion in human hilar cholangiocarcinomas].
    Li Z; Zhang L; Zou S
    Zhonghua Yi Xue Za Zhi; 2002 May; 82(9):606-9. PubMed ID: 12133481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dephosphorylation of autoantigenic ribosomal P proteins during Fas-L induced apoptosis: a possible trigger for the development of the autoimmune response in patients with systemic lupus erythematosus.
    Zampieri S; Degen W; Ghiradello A; Doria A; van Venrooij WJ
    Ann Rheum Dis; 2001 Jan; 60(1):72-6. PubMed ID: 11114288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tickling the CD200 receptor: A remedy for those irritating macrophages.
    Feuer R
    Am J Pathol; 2007 Aug; 171(2):396-8. PubMed ID: 17600125
    [No Abstract]   [Full Text] [Related]  

  • 18. Fas ligand-positive membranous vesicles isolated from sera of patients with oral cancer induce apoptosis of activated T lymphocytes.
    Kim JW; Wieckowski E; Taylor DD; Reichert TE; Watkins S; Whiteside TL
    Clin Cancer Res; 2005 Feb; 11(3):1010-20. PubMed ID: 15709166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody mAb33 from transduction laboratories detects human CD95L in ELISA but not in immunoblots.
    Fiedler P; Eibel H
    Cell Death Differ; 2000 Jan; 7(1):126-8. PubMed ID: 10858071
    [No Abstract]   [Full Text] [Related]  

  • 20. Fas ligand and immune evasion.
    Nagata S
    Nat Med; 1996 Dec; 2(12):1306-7. PubMed ID: 8946823
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.